π
|
Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial.
8 auth.
V. Aroda,
Stephen C. Bain,
B. Cariou,
M. Piletic,
L. Rose,
M. Axelsen,
...
E. Rowe,
J. DeVries
|
8 |
2017 |
8 π
|
π
|
A Narrative Review of Chronic Kidney Disease in Clinical Practice: Current Challenges and Future Perspectives
11 auth.
M. Evans,
Ruth D. Lewis,
A. Morgan,
M. Whyte,
W. Hanif,
Stephen C. Bain,
...
Sarah Davies,
U. Dashora,
Z. Yousef,
D. Patel,
W. Strain
|
6 |
2021 |
6 π
|
π
|
Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER
13 auth.
Ahmed M. Shaman,
Stephen C. Bain,
G. Bakris,
J. Buse,
Thomas Idorn,
K. Mahaffey,
J. Mann,
M. Nauck,
S. Rasmussen,
P. Rossing,
...
B. Wolthers,
B. Zinman,
V. Perkovic
|
6 |
2021 |
6 π
|
π
|
Abstracts of the 49th Annual Meeting of the EASD
10 auth.
M. Campbell,
M. Walker,
M. Trenell,
S. Luzio,
G. Dunseath,
E. Stevenson,
...
R. Bracken,
D. Turner,
Stephen C. Bain,
D. West
|
6 |
2013 |
6 π
|
π’
|
Association of Apolipoprotein Ξ΅2 Allele With Diabetic Nephropathy in Caucasian Subjects With IDDM
17 auth.
T. Chowdhury,
P. Dyer,
Sudesh Kumar,
S. P. Gibson,
B. R. Rowe,
S. Davies,
S. Marshall,
Peter J. Morris,
G. Gill,
S. Feeney,
...
P. Maxwell,
D. Savage,
A. Boulton,
J. Todd,
D. Dunger,
A. Barnett,
Stephen C. Bain
|
6 |
1998 |
6 π’
|
π’
|
Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared to placebo.
8 auth.
K. Tuttle,
H. BoschβTraberg,
D. Cherney,
S. Hadjadj,
J. Lawson,
Ofri Mosenzon,
...
S. Rasmussen,
Stephen C. Bain
|
5 |
2023 |
5 π’
|
π
|
Simulated games activity versus continuous running exercise: a novel comparison of the glycaemic and metabolic responses in T1DM patients
10 auth.
M. Campbell,
D. West,
Stephen C. Bain,
Michael I. C. Kingsley,
P. Foley,
L. Kilduff,
...
D. Turner,
B. Gray,
J. W. Stephens,
R. Bracken
|
5 |
2013 |
5 π
|
π’
|
Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus.
12 auth.
J. Stephens,
T. Bodvarsdottir,
K. Wareham,
Sarah L. Prior,
R. Bracken,
G. Lowe,
...
A. Rumley,
G. Dunseath,
S. Luzio,
C. Deacon,
J. Holst,
Stephen C. Bain
|
5 |
2011 |
5 π’
|
π¦
|
The British Diabetic Association -Warren Repository
Stephen C. Bain,
J. Todd,
A. Barnett
|
5 |
1990 |
5 π¦
|